Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
67
NDAQ Quote, Financials, Valuation and Earnings
Last price:
$75.74
Seasonality move
:
4.62%
Day range:
$74.48 - $76.14
52-week range:
$58.28 - $84.15
Dividend yield:
1.26%
P/E ratio:
34.52x
P/S ratio:
5.63x
P/B ratio:
3.78x
Volume:
1.8M
Avg. volume:
3.4M
1-year change:
26.4%
Market cap:
$43.6B
Revenue:
$7.4B
EPS (TTM):
$2.20
Analysts' Opinion
-
Consensus RatingNasdaq has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 6 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $83.72, Nasdaq has an estimated upside of 10.25% from its current price of $75.94.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $68.00 representing 10.46% downside risk from its current price of $75.94.
Fair Value
-
According to the consensus of 12 analysts, Nasdaq has 10.25% upside to fair value with a price target of $83.72 per share.
NDAQ vs. S&P 500
-
Over the past 5 trading days, Nasdaq has overperformed the S&P 500 by 3.04% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nasdaq does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nasdaq has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Nasdaq reported revenues of $2.1B.
Earnings Growth
-
Nasdaq has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Nasdaq reported earnings per share of $0.68.
Enterprise value:
50.4B
EV / Invested capital:
2.41x
Price / LTM sales:
5.63x
EV / EBIT:
25.06x
EV / Revenue:
6.45x
PEG ratio (5yr expected):
2.19x
EV / Free cash flow:
27.16x
Price / Operating cash flow:
23.72x
Enterprise value / EBITDA:
19.19x
Gross Profit (TTM):
$3.1B
Return On Assets:
4.2%
Net Income Margin (TTM):
16.36%
Return On Equity:
11.5%
Return On Invested Capital:
6.14%
Operating Margin:
27.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $6.2B | $6.2B | $7.8B | $1.7B | $2.1B | |
| Gross Profit | $2.4B | $2.7B | $3.1B | $701M | $816M | |
| Operating Income | $1.7B | $1.8B | $2.1B | $445M | $576M | |
| EBITDA | $1.9B | $2.1B | $2.6B | $570M | $736M | |
| Diluted EPS | $2.30 | $1.90 | $2.20 | $0.40 | $0.68 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.7B | $8.2B | $8.5B | $7.3B | $7.8B | |
| Total Assets | $18.5B | $20.8B | $20.8B | $30.3B | $30.6B | |
| Current Liabilities | $5.6B | $8.9B | $8.7B | $7.4B | $8B | |
| Total Liabilities | $12.2B | $14.8B | $14.6B | $19.4B | $19.1B | |
| Total Equity | $6.3B | $6B | $6.2B | $10.8B | $11.6B | |
| Total Debt | $5.9B | $5.9B | $5.1B | $10B | $9.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.7B | $1.7B | $2.1B | $530M | $663M | |
| Cash From Investing | $306M | -$6.1B | -$979M | -$232M | -$258M | |
| Cash From Financing | $55M | $3B | -$1.8B | -$1.9B | -$1.1B | |
| Free Cash Flow | $1.5B | $1.5B | $1.9B | $491M | $614M | |
NDAQ
Sector
Market Cap
$43.6B
$603.7M
Price % of 52-Week High
90.24%
84.45%
Dividend Yield
1.26%
2.05%
Shareholder Yield
2.38%
3.98%
1-Year Price Total Return
26.4%
9.07%
Beta (5-Year)
1.021
0.555
Dividend yield:
1.26%
Annualized payout:
$0.94
Payout ratio:
43.19%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$73.77
200-day SMA
Buy
Level
$74.98
Bollinger Bands (100)
Sell
Level
73.96 - 81.46
Chaikin Money Flow
Buy
Level
547.7M
20-day SMA
Buy
Level
$72.61
Relative Strength Index (RSI14)
Buy
Level
55.93
ADX Line
Buy
Level
14.98
Williams %R
Sell
Level
-1.9157
50-day SMA
Buy
Level
$75.67
MACD (12, 26)
Sell
Level
-0.11
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
706.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.216)
Sell
CA Score
(Annual)
Level (-0.7913)
Buy
Beneish M-Score
(Annual)
Level (-2.4603)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.1591)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as the firm seeks to become a diversified technology company.
Stock Forecast FAQ
In the current month, NDAQ has received 6 Buy ratings 6 Hold ratings, and 0 Sell ratings. The NDAQ average analyst price target in the past 3 months is $83.72.
-
Where Will Nasdaq Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nasdaq share price will rise to $83.72 per share over the next 12 months.
-
What Do Analysts Say About Nasdaq?
Analysts are divided on their view about Nasdaq share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nasdaq is a Sell and believe this share price will drop from its current level to $68.00.
-
What Is Nasdaq's Price Target?
The price target for Nasdaq over the next 1-year time period is forecast to be $83.72 according to 12 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is NDAQ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nasdaq is a Leans Bullish. 6 of 12 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of NDAQ?
You can purchase shares of Nasdaq via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nasdaq shares.
-
What Is The Nasdaq Share Price Today?
Nasdaq was last trading at $75.74 per share. This represents the most recent stock quote for Nasdaq. Yesterday, Nasdaq closed at $75.94 per share.
-
How To Buy Nasdaq Stock Online?
In order to purchase Nasdaq stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
